{"date":"2025-04-29","count":40,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6926-2025-04-29-2222-1vrztj0","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"22:22:30","subject":"公告本公司董事會決議委任第二屆薪資報酬委員會委員","clause":"第6款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-04-29 22:22，「公告本公司董事會決議委任第二屆薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-04-29-2154-404p2v","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"21:54:09","subject":"公告本公司第二屆審計委員會委員","clause":"第6款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-04-29 21:54，「公告本公司第二屆審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-04-29-2122-s0kpz3","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"21:22:14","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-04-29 21:22，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-04-29-2049-18h6riz","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"20:49:08","subject":"公告本公司114年股東常會通過解除董事及其代表人競業禁止之限制案","clause":"第22款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-04-29 20:49，「公告本公司114年股東常會通過解除董事及其代表人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-04-29-2027-147ot3p","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"20:27:13","subject":"代重要子公司Belite Bio, Inc公告受邀參加美國視覺與眼科協會ARVO 2025年會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-04-29 20:27，「代重要子公司Belite Bio, Inc公告受邀參加美國視覺與眼科協會ARVO 2025年會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6734-2025-04-29-1948-gurs79","company_id":"6734","company":"安盛生","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"19:48:04","subject":"公告本公司114年3月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安盛生（6734），2025-04-29 19:48，「公告本公司114年3月份自結財務報告之負債比率、流動比率、速動比率、預估未來三個月現金收支情形及銀行可使用融資額度情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-04-29-1943-1fdtui6","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"19:43:53","subject":"公告本公司114年股東常會改選第三屆董事(含獨立董事)當選名單","clause":"第6款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-04-29 19:43，「公告本公司114年股東常會改選第三屆董事(含獨立董事)當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-04-29-1927-1pcdnys","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"19:27:31","subject":"公告本公司2025年第1季合併財務報告董事會預計召開日期為2025年5月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-04-29 19:27，「公告本公司2025年第1季合併財務報告董事會預計召開日期為2025年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-04-29-1925-p67uuk","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-04-29","time":"19:25:18","subject":"公告本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-04-29 19:25，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-04-29-1923-92x690","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-04-29","time":"19:23:44","subject":"董事會決議股利分派","clause":"第14款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-04-29 19:23，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-04-29-1921-bathak","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-04-29","time":"19:21:45","subject":"公告本公司提報董事會2025年第1季合併財務報告","clause":"第31款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-04-29 19:21，「公告本公司提報董事會2025年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-04-29-1910-1s7xzm3","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"19:10:54","subject":"公告本公司向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-04-29 19:10，「公告本公司向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-04-29-1854-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"18:54:40","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-04-29 18:54，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-04-29-1840-1yvwb7f","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"18:40:07","subject":"公告本公司董事會決議通過成立永續發展委員會及委任第一屆永續發展委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-04-29 18:40，「公告本公司董事會決議通過成立永續發展委員會及委任第一屆永續發展委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-04-29-1839-1aoweer","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"18:39:47","subject":"公告本公司董事會通過公司治理主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-04-29 18:39，「公告本公司董事會通過公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-04-29-1839-ifuzqn","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"18:39:31","subject":"公告本公司董事會通過114年第一季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-04-29 18:39，「公告本公司董事會通過114年第一季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-04-29-1821-ds864w","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"18:21:50","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-04-29 18:21，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-04-29-1759-q17qxk","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"17:59:06","subject":"本公司114年第一季財務報告董事會預計召開日期為114年5月7日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-04-29 17:59，「本公司114年第一季財務報告董事會預計召開日期為114年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1789-2025-04-29-1757-1of6yin","company_id":"1789","company":"神隆","market":"上市","industry":"生技醫療","date":"2025-04-29","time":"17:57:11","subject":"公告本公司114年第一季合併財務報告董事會預計召開日期為114年05月07日","clause":"第31款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：神隆（1789），2025-04-29 17:57，「公告本公司114年第一季合併財務報告董事會預計召開日期為114年05月07日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-29-1749-13af8ez","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"17:49:29","subject":"本公司受邀參加第一金證券舉辦之線上法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-29 17:49，「本公司受邀參加第一金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-04-29-1749-omygpj","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"17:49:07","subject":"代子公司Handa Pharmaceuticals, LLC公告與美國反壟斷案全部最終付費原告達成和解協議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-04-29 17:49，「代子公司Handa Pharmaceuticals, LLC公告與美國反壟斷案全部最終付費原告達成和解協議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-04-29-1748-1himfj3","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"17:48:56","subject":"公告114年第一季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-04-29 17:48，「公告114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1813-2025-04-29-1703-3yi0lb","company_id":"1813","company":"寶利徠","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"17:03:30","subject":"公告本公司114年第1季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：寶利徠（1813），2025-04-29 17:03，「公告本公司114年第1季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-04-29-1631-bwopfv","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:31:42","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-04-29 16:31，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-29-1629-84656m","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:29:10","subject":"公告本公司董事會通過內部稽核主管任命案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-29 16:29，「公告本公司董事會通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-29-1627-5rax5d","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:27:08","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-29 16:27，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-04-29-1626-1hku5w3","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:26:47","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-04-29 16:26，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-04-29-1624-5rax5d","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:24:25","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-04-29 16:24，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-29-1623-1rpjgd9","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:23:02","subject":"公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-29 16:23，「公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-04-29-1621-1s04pqb","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:21:04","subject":"公告本公司董事會決議召開114年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-04-29 16:21，「公告本公司董事會決議召開114年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1777-2025-04-29-1612-dru0st","company_id":"1777","company":"生泰","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"16:12:24","subject":"公告114年第1季財務報告董事會預計召開日期為114年5月7日","clause":"第31款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：生泰（1777），2025-04-29 16:12，「公告114年第1季財務報告董事會預計召開日期為114年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-04-29-1604-8hqjh3","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"16:04:09","subject":"本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-04-29 16:04，「本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-04-29-1603-1g62dwo","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-04-29","time":"16:03:58","subject":"公告本公司受邀參加國泰證券舉辦線上法人說明會","clause":"第30款","fact_date":"2025-05-13","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-04-29 16:03，「公告本公司受邀參加國泰證券舉辦線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-04-29-1601-q87jdd","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-04-29","time":"16:01:09","subject":"公告本公司將於114年05月06舉辦上市前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-04-29 16:01，「公告本公司將於114年05月06舉辦上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-04-29-1538-6xgf5h","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-04-29","time":"15:38:05","subject":"公告本公司114年度第一季合併財務報告董事會預計召開日期為114年5月7日","clause":"第31款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-04-29 15:38，「公告本公司114年度第一季合併財務報告董事會預計召開日期為114年5月7日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4911-2025-04-29-1422-oh6ex5","company_id":"4911","company":"德英","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"14:22:11","subject":"公告本公司114年第一季財務報告董事會召開日期","clause":"第31款","fact_date":"2025-04-29","cite_as":"公開資訊觀測站重大訊息：德英（4911），2025-04-29 14:22，「公告本公司114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4183-2025-04-29-1400-1himfj3","company_id":"4183","company":"福永生技","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"14:00:32","subject":"公告114年第一季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：福永生技（4183），2025-04-29 14:00，「公告114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6733-2025-04-29-1314-oh6ex5","company_id":"6733","company":"博晟生醫","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"13:14:54","subject":"公告本公司114年第一季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：博晟生醫（6733），2025-04-29 13:14，「公告本公司114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-04-29-1311-oh6ex5","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"13:11:09","subject":"公告本公司114年第一季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-04-29 13:11，「公告本公司114年第一季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-04-29-1036-1glgeuv","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-04-29","time":"10:36:48","subject":"康和證券邀請本公司參加法人說明會","clause":"第12款","fact_date":"2025-04-30","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-04-29 10:36，「康和證券邀請本公司參加法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}